Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Tyson Foods, Inc. (TSN) vs GeneDx Holdings Corp (WGS) Price & Performance

Tyson Foods, Inc.Trade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Tyson Foods, Inc. vs GeneDx Holdings Corp — how do they compare? Tyson Foods, Inc. trades at $56.22 (market cap $19.85B), while GeneDx Holdings Corp trades at $82.28 (market cap $2.44B). The key difference: Tyson Foods, Inc. is far larger — about 8.1× GeneDx Holdings Corp's market cap, and Tyson Foods, Inc. pays a 3.62% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

TSNWGS
Market Cap
$19.85B$2.44B
Sector
Consumer StaplesTechnology
52-Week High
$68.75$167.51
52-Week Low
$50.72$34.51
Enterprise Value
$27.12B$2.48B
Dividend Yield
3.62%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Tyson Foods, Inc.

Tyson Foods (TSN) trades at $55.85, down 2.29% today, reflecting bearish technical signals and mixed fundamentals. Recent Q3 2026 earnings of $0.99 per share beat estimates, but revenue missed expectations amid declining volumes. The company faces headwinds from persistent losses in its beef segment, though chicken and prepared foods remain profitable. Analyst consensus is a 'Buy' with a $68.50 price target, suggesting significant upside potential from current levels.

The outlook hinges on Tyson's ability to stabilize beef margins while leveraging strength in other segments. Investment appeal lies in its low P/S ratio of 0.36 and dividend yield, but risks include volatile commodity costs and execution challenges. Near-term performance will depend on Q3 2026 results and management's guidance update.

GeneDx Holdings Corp

GeneDx Holdings Corp (WGS) trades at $82.36, up 5.75% in 24 hours, with a bullish technical signal and strong analyst support. Recent Q2 2026 results beat expectations with $0.01 EPS and record testing volumes, though net income margins remain negative. The stock faces class action litigation risks but benefits from institutional buying and new product launches.

Outlook is mixed: bullish technicals and 91% buy ratings suggest upside to the $90 high target, but negative profitability and legal overhangs pose risks. Investors should weigh growth potential against financial sustainability and litigation outcomes.

Returns comparison

Trailing returns across standard periods

About Tyson Foods, Inc.

Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.

Read more on TSN

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS